Liver Cancer
Copyright ©The Author(s) 2004.
World J Gastroenterol. Aug 1, 2004; 10(15): 2184-2189
Published online Aug 1, 2004. doi: 10.3748/wjg.v10.i15.2184
Figure 1
Figure 1 Actuarial survival of 94 patients treated with 3D-CRT combined with TACE.
Figure 2
Figure 2 Univariate analysis of age on survival of patients treated with 3D-CRT combined with TACE.
Figure 3
Figure 3 Univariate analysis of Child-Pugh classification on survival of patients treated with 3D-CRT combined with TACE.
Figure 4
Figure 4 Univariate analysis of Okuda stage on survival of patients treated with 3D-CRT combined with TACE.
Figure 5
Figure 5 Univariate analysis of tumor size on survival of pa-tients treated with 3D-CRT combined with TACE.
Figure 6
Figure 6 Univariate analysis of tumor type on survival of patients treated with 3D-CRT combined with TACE.
Figure 7
Figure 7 Univariate analysis of albuminemia on survival of patients treated with 3D-CRT combined with TACE.
Figure 8
Figure 8 Univariate analysis of radiation dose on survival of patients treated with 3D-CRT combined with TACE.